7071 — Amvis Holdings Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapContrarian

Annual income statement for Amvis Holdings, fiscal year end - September 30th, JPY millions except per share, conversion factor applied.

	R2020 September 30th	2021 September 30th	2022 September 30th	2023 September 30th	2024 September 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	9,174	15,334	23,072	31,985	42,475
Cost of Revenue
Gross Profit	3,750	6,305	9,687	13,271	17,060
Selling / General / Administrative Expenses
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	7,299	11,550	16,940	22,955	31,863
Operating Profit	1,875	3,784	6,132	9,030	10,612
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,777	3,779	6,060	8,942	10,551
Provision for Income Taxes
Net Income After Taxes	1,239	2,628	4,280	6,311	7,439
Net Income Before Extraordinary Items
Net Income	1,239	2,628	4,280	6,311	7,439
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	1,239	2,627	4,279	6,310	7,438
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	13.6	27.7	43.7	61.2	75.8
Dividends per Share